Background: Black persons are more likely than white persons to be diagnosed with colorectal cancer and to die from it. The extent to which genetic or biological factors versus disparities in screening rates explain this variance remains controversial.
C
olorectal cancer (CRC) currently ranks as the third most common cancer and second-leading cause of cancer-related death among men and women in the United States (1) . Despite recent declines in overall incidence of CRC and mortality, black persons are more likely to be diagnosed with CRC and to die from it than white persons (2) . Understanding the factors contributing to these disparities has been elusive. Although differential access to and uptake of care, particularly screenings (3) (4) (5) , have been identified as potential contributors, evidence suggests that biological and genetic factors may play an important role (6, 7) . Differences in the molecular composition of tumors (8, 9) , age of onset (10, 11) , and anatomical distribution of disease in the colon (10) lend credence to the putative role of these factors. Nevertheless, U.S. age-adjusted incidence rates were consistently lower among black men than white men and similar for black and white women in the 1980s (12) , which suggests that lack of appropriate screening may be the more important cause (13) .
Understanding the age-adjusted prevalence and distribution of presymptomatic advanced colorectal neoplasia (ACN) would shed light on this controversy. However, studies to date have provided conflicting results, with some finding a higher prevalence among black persons and others finding no difference (14 -17) . Possible explanations include differences in the primary end point (for example, polyp size vs. histopathology) or selection criteria, racial misclassification, ethnic mix, and differential exposure to modifiable risk factors for ACN. Findings about the anatomical location of ACN also conflict (14 -17) . Therefore, our overall objective was to compare the prevalence and distribution of ACN among average-risk white and black persons undergoing screening colonoscopy in a safety-net hospital while controlling for exposure to other epidemiologic risk factors.
METHODS

Study Design
We conducted a cross-sectional study of consecutive, asymptomatic, average-risk patients undergoing openaccess screening colonoscopy between 22 March 2005 and 31 January 2012. Potential study participants were identified from daily appointment logs and assessed for eligibility by a study coordinator in the endoscopy unit before their scheduled procedure. The study protocol was approved by the Institutional Review Board of Boston University Medical Campus.
Setting and Participants
Boston Medical Center is a private, not-for-profit, community-based, academic medical center. It is the largest safety-net hospital in New England, with 18 affiliated community health centers and a legislative mandate to provide care to low-income persons and other vulnerable populations regardless of their ability to pay. Approximately 70% of the center's patients are from racial (44% black persons) and ethnic minority groups and more than 95% have some form of health care insurance. During this study, cumulative screening rates for white and black persons were approximately 55% and 58%, respectively, with colonoscopies accounting for 89% of the completed tests for both groups.
Participants were aged 50 to 79 years, were due for CRC screening in accordance with current guidelines, and categorized themselves as non-Hispanic white or nonHispanic black. Patients with other indications, such as lower gastrointestinal symptoms, iron deficiency anemia, positive fecal occult blood test results, or surveillance because of a history of colorectal neoplasia or chronic inflammatory bowel disease, were ineligible. Patients undergoing screening because of a family history of CRC affecting a first-degree relative of any age or colorectal polyps affecting a first-degree relative before age 60 years were also ineligible.
Survey Method
Consenting patients with adequate literacy skills selfadministered the risk assessment questionnaire (a coded, scannable, paper-based collection form devoid of identifiable patient information). Trained interviewers assisted patients with low literacy skills. The questionnaire took approximately 5 minutes to complete.
The questionnaire initially comprised 38 items that included all 21 items of the original Your Disease Risk (YDR) assessment tool for CRC and 17 additional items related to putative risk factors not included in the YDR index (Supplement 1, available at www.annals.org). The original YDR index was a Web-based adaptation of the Harvard Cancer Risk Index (18) , which had been validated for CRC by using data from the Nurses' Health Study and the Health Professionals' Follow-up Study (19) . The questionnaire was modified in July 2007 (Supplement 2, available at www.annals.org) to reflect changes in the YDR index based on an updated review of the literature (20) . Relevant changes included omission of the vegetable intake item and addition of a dairy one. We expanded previous screening behavior to include virtual colonoscopy and stool-based DNA testing. The 17 additional items not included in the YDR index related to race or ethnicity, smoking (21) , dose or duration of aspirin and other nonsteroidal anti-inflammatory drug use (22, 23) , history of diabetes mellitus (24) , and family history of colorectal polyps (25) . Items related to family history, inflammatory bowel disease, and previous screening behavior provided an internal check for eligibility. The age, height, and weight items used a fill-in-the-blank format; all other items used a best-answer tick-box format.
Colonoscopy Findings and Histology
All screening colonoscopies were performed by boardcertified attending gastroenterologists alone or assisted by a gastroenterology fellow. Endoscopic data, including the size and location of any polyps or masses, depth of scope insertion, and quality of the bowel preparation, were abstracted from the computerized colonoscopy reports. Polyps or masses located in the rectum, sigmoid, descending colon, or splenic flexure were classified as distal, whereas those located in the transverse colon, hepatic flexure, ascending colon, or cecum were classified as proximal. All retrieved polypoid lesions or biopsy specimens were reviewed initially by board-certified pathologists and classified according to the World Health Organization's histologic criteria as normal mucosa, serrated lesions, conventional adenomas, or invasive cancer (26) ; each also had a second review by a gastrointestinal pathologist with expertise in colorectal neoplasia. Adenomas were subclassified as tubular, tubulovillous, or villous with or without highgrade dysplasia; conversely, serrated lesions were subclassified as hyperplastic polyps, sessile serrated adenomas or polyps with or without cytologic dysplasia, and traditional serrated adenomas (26) . An advanced colorectal neoplasm
Context
Some studies in the United States show that black persons have higher colorectal cancer incidence and mortality than other racial groups.
Contribution
This study of average-risk adults undergoing screening colonoscopy found that the prevalence of advanced colorectal neoplasia (ACN) was higher among white persons than black persons (6.8% vs. 5.0%). Analyses that controlled for multiple risk factors showed that black men were 41% less likely than white men to have ACN. Such analyses were inconclusive for women.
Caution
Data were from a single, urban, academic hospital in Massachusetts.
Implication
Disparities in access to screening seem more likely than biological factors to explain the higher risk for ACN among black compared with white men.
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Original Research Advanced Colorectal Neoplasia in White and Black Patients was defined as a tubular adenoma 10 mm or more in size, an adenoma of any size with villous features or high-grade dysplasia, a dysplastic serrated lesion of any size, or invasive cancer (27) . Patients with several polyps submitted individually or collectively in a single specimen container were classified on the basis of their most advanced histologic characteristics.
Statistical Analysis
The primary analysis examined racial differences in the overall prevalence of ACN after adjustment for other risk factors in a multivariate analysis. The secondary analysis examined racial differences in the distribution of proximal ACN versus distal ACN among persons with ACN. Patients with incomplete examinations due to poor bowel preparation or failure to reach the cecum for reasons other than poor bowel preparation or an obstructing neoplasm were excluded from analysis if they did not undergo a complete examination within 1 year. Patients with unretrieved polyp specimens were also excluded. On the basis of results from a previous retrospective analysis (28), we estimated that a target sample of 1156 patients in each group provided 80% power for detecting a 6.2% versus 3.6% difference in ACN prevalence (2-tailed P Ͻ 0.05).
Demographic factors and findings at colonoscopy among black and white persons were compared by using the 2-sample t-test for continuous variables and the chisquare test or Fisher exact test for categorical variables. Differences in the prevalence of ACN between white and black persons were examined with chi-square analyses or Fisher exact tests after stratification by age and sex. We used multiple logistic regression analysis to obtain adjusted odds ratios (AORs) and 95% CIs to describe the associations between race and ACN, controlling first for age and sex and then for the risk factors listed in Table 1 . Age, body mass index, and height were treated as continuous covariates in these regressions; data on other risk factors were collected from categorical responses and dichoto- mized for analysis. Racial differences in CRC differed for men and women, so interaction terms examined whether differences in the odds of ACN between black and white adults varied by sex and age. Secondary analyses examined racial differences in the prevalence of proximal ACN among patients with ACN by using logistic regression models controlling for age and sex. We did sensitivity analyses to determine whether the exclusion of patients with poor bowel preparation or the presence of an unmeasured dichotomous confounder affected the robustness of our results (29) .
Modifications to the risk assessment questionnaire during the study led to missing data on dairy intake and diabetes for the first 772 participants. We therefore used multiple imputation to include all patients in the adjusted analysis and PROC MI and PROC MIANALYZE in SAS (SAS Institute, Cary, North Carolina) to generate and analyze 5 imputed data sets. We used Markov-chain Monte Carlo methods to impute continuous, missing body mass index values (n ϭ 65), and binary and ordinal logistic regression models to impute missing risk factor data based on demographic and other risk factors. Because of the number of covariates included in the adjusted analyses, we examined variance inflation factors to assess collinearity between covariates. No problems with collinearity were identified; sex had the highest variance inflation factor of 2.0, which decreased to 1.4 if height was excluded, and all other variables were below 1.5.
All statistical calculations were done by using SAS, version 9.2, with significance being defined at the 2-tailed P value less than 0.05 for all analyses.
Role of the Funding Source
The National Cancer Institute funded the study but had no role in the design, conduct, analysis, or the decision to submit the manuscript for publication.
RESULTS
Study Population
A total of 3321 potentially eligible patients presumed to be of average risk were referred for screening colonoscopy, including 1385 white persons and 1936 black persons. The Figure depicts the number of potentially eligible patients for each group who declined to participate, were deemed ineligible based on inclusion or exclusion criteria, or were excluded because of inadequate bowel preparation, incomplete colonoscopy, or failed polyp retrieval. The evaluable study population comprised 1172 white persons and 1681 black persons. As shown in Table 1 , both groups had a mean age of approximately 56 years. They were similar with respect to age distribution and colonoscopy experience, with 92% completing their initial examination; however, they differed with respect to sex (P Ͻ 0.001), with a predominance of men in the white cohort (57%) and women in the black cohort (52%), which is similar to the racial distribution of white (54% male) and black (56% female) patients at Boston Medical Center. Differences were also observed for education, insurance, and most epidemiologic risk factors. The racial distribution of patients among the 22 participating endoscopists was roughly balanced, with each examining a mean of 42% (SD, 15%) white adults and 58% (SD, 14%) black adults (data not shown). Characteristics of the 2 study groups stratified by sex are provided in Appendix Tables 1 and 2 (available at www.annals.org).
Unadjusted Prevalence and Location of ACN
As shown in Table 2 , the prevalence of ACN was significantly higher among white patients than black patients (6.8% vs. 5.0%; P ϭ 0.039). White patients were also more likely to present with 3 or more nonadvanced adenomas, a marker for metachronous ACN (30, 31) , and nonadvanced adenomas 6 to 9 mm in size. Although the difference in ACN between white and black adults overall Original Research Advanced Colorectal Neoplasia in White and Black Patients was largely attributable to tubular adenomas 10 mm or more in size (4.3% vs. 2.7%; P ϭ 0.020), the distribution of histologic subtypes among those with ACN did not apparently differ (P ϭ 0.55). With respect to anatomical location, white patients were more likely to present with distal ACN (4.2% vs. 2.4%; P ϭ 0.007), whereas the prevalence of proximal ACN was similar for the 2 groups (2.6% vs. 2.6%; P ϭ 0.96). However, among black patients with ACN, there was a predilection for proximal disease but the difference was not statistically significant (52% vs. 39%; P ϭ 0.080). Similar analyses were performed after stratification by age and sex (Appendix Table 3 , available at www.annals .org). They suggested that the prevalence of ACN was higher among white adults than black adults aged 50 to 59, 60 to 69, and 70 to 79 years, although estimates were imprecise due to small numbers in each subgroup. After stratification by sex, the prevalence of ACN was significantly higher for white men than black men overall (9.3% vs. 5.7%), particularly for white men younger than 60 years (9.0% vs. 5.2%). Differences between white and black women, overall and by age, were inconclusive, probably due to the low prevalence of ACN in these subgroups.
Adjusted Prevalence of ACN
Results from a logistic regression model with terms for race, age, and sex supported the inclusion of an interaction term for race by sex (P ϭ 0.034) but not race by age (P ϭ 0.20). After controlling for the risk factors in Table 3) .
Among individuals with ACN, a higher percentage of black persons had proximal disease (52% vs. 39%) after adjustment for age and sex (P ϭ 0.055). This predilection for proximal location was seen in both black men (54.3% vs. 40.3%) and black women (50.0% vs. 33.3%).
Sensitivity Analysis
We conducted a sensitivity analysis to explore the effect of excluding the 135 patients (51 black and 25 white men; 42 black and 17 white women) with poor bowel preparation. If these patients had 3 times the odds of ACN as those with adequate preparation, their inclusion would increase the unadjusted odds of ACN for black men from the observed 0.59 to 0.61 (CI, 0.42 to 0.89) and for black women from 1.23 to 1.26 (CI, 0.73 to 2.17). We also explored the effect of an unmeasured covariate on the lower AOR for black men. Results would remain statistically significant unless the association between the confounder and ACN is moderately strong (AOR Ն2.0) and the risk factor was substantially more prevalent in white adults than black adults (for example, 30% vs. 10% or 40% vs. 20%) (Appendix Table 4 , available at www.annals .org).
DISCUSSION
Our study affirms the importance of race as an independent risk factor. However, contrary to the results of several previously published studies (14 -17), we found that the prevalence of ACN was higher among white persons than black persons overall, especially white men compared with black men after adjustment for other known CRC risk factors. Although no statistically significant differences were seen between white and black women, our findings are inconclusive, presumably due to the low prevalence of ACN in this subgroup. Like other studies (14, 15, 17) , we observed a predilection for proximal disease among black persons compared with white persons with ACN. The findings related to differences in the overall prevalence of ACN are noteworthy because similar sexspecific relationships were observed for CRC incidence rates among white and black persons before the increase in screening rates (12) . These findings are also consistent with results from a Microsimulation Screening Analysis that estimated that 51% of the disparity in CRC incidence rate for black versus white men and 32% for white versus black women could be explained by differences in screening (13) .
Previous studies comparing the prevalence and location of ACN among white and black persons have provided conflicting results. The largest such study by Lieberman and associates (14) used pooled data from the Clinical Outcomes Research Initiative and found that the prevalence of polyps greater than 9 mm in size, a surrogate for ACN, was higher among both black men and women after adjustment for age, sex, and family history. Lebwohl and colleagues (17) also saw a higher rate of ACN for both black men and women by using conventional histopathologic criteria after adjustments for age, sex, family history, insurance status, and trainee participation. Conversely, the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (15) and a study by Friedenberg and colleagues (16) found no association between race and ACN. The 4 studies also exhibited disparate results with respect to location of disease, with 2 studies finding a higher prevalence of proximal ACN among black persons overall (15, 17) , 1 study finding a higher prevalence among black persons older than 60 years but not overall (14) , and 1 study finding no difference (16) . We speculate that differences in the primary end point (for example, polyp size vs. histopathology), racial misclassification, ethnic mix, and differential exposure to modifiable risk factors for ACN (for example, smoking or previous colonoscopy) may explain this variance.
Our study has several noteworthy strengths that lend credence to our findings. First, the prospective enrollment of patients enabled us to control for previous colonoscopy and other epidemiologic risk factors, thus minimizing confounding. Second, the safety-net health care setting provided a unique opportunity to assess the prevalence of ACN among a patient population devoid of many of the financial barriers to access CRC screening present in other health care settings. Third, we used a more valid measure of ACN than polyp size alone to define our outcome of interest because 10% to 20% of polyps 10 mm or larger will be nonneoplastic and 2% to 10% of polyps smaller than 10 mm will have advanced histologic characteristics BMI ϭ body mass index; HRT ϭ hormone replacement therapy; NSAID ϭ nonsteroidal anti-inflammatory drug; OR ϭ odds ratio. * Logistic regression with adjustment for age and risk factors listed in Table 1 , and the use of multiple imputation to account for missing data for dairy intake and diabetes mellitus. The model included an interaction term for race by sex (P ϭ 0.034). † Daily use of a calcium supplement or Ն3 servings of milk or dairy daily. ‡ Includes patients who took a multivitamin.
Original Research Advanced Colorectal Neoplasia in White and Black Patients (32) (33) (34) (35) . Lastly, we restricted our analyses to patients with complete examinations, adequate bowel preparations, and complete retrieval of all polyp specimens to minimize misclassification. Our study also has several important limitations. First, we conducted it at a single, urban, academic medical center, so our findings may not be generalizable to other health care settings in geographic regions where ethnic mix or exposure rates to modifiable risk factors may differ. Because of the widespread disparities in access to colonoscopy in most other health settings, however, we believe that the internal validity of our findings may be more relevant than their external validity. Second, the use of a convenience sample raises concern about potential selection bias; however, this is offset by the fact that black and white patients had equal access to screening colonoscopy, were recruited consecutively, and had high enrollment. Third, we lacked sufficient statistical power for many of our subgroup analyses, particularly women, because of the relatively low prevalence of disease. Fourth, our study design does not preclude the possibility of length-time bias as an explanation for the higher incidence of cancer among black adults. Nevertheless, cancer registry data for Massachusetts from 2000 to 2009 (36, 37) , which has among the highest CRC screening rates in the nation for white and black persons, reveals lower age-adjusted CRC incidence rates among black persons than white persons of both sexes, thus reducing the likelihood of length-of-time bias (2) . Fifth, although patients were recruited prospectively, our response data from the questionnaire is subject to recall bias. Sixth, although our data on race and ethnicity were measured by self-report, misclassification remains a possibility because of mixed ancestry, acculturation, and assimilation. Seventh, the reliance on subjective estimates of polyp size at endoscopy may have resulted in misclassification. The observation that white persons were also more likely than black persons to present with nonadvanced adenomas 6 to 9 mm in size lessens this concern. Lastly, our selection criteria precluded a comparison of ACN prevalence in persons younger than 50 years and cannot shed light on recommendations by some professional groups to initiate screening for black adults at age 45 years (38, 39) .
Despite these limitations, our findings have important public health implications because they highlight the need for strategies focused on increasing screening rates among black persons in settings where disparities exist. These strategies must not only address barriers to access (such as lack of health care insurance) but also patient-and physician-level barriers to acceptance, adherence, and use. Despite the predilection for proximal disease among black patients with ACN, the relatively high proportion of patients with proximal disease in both groups supports the use of colonoscopy over flexible sigmoidoscopy for white and black persons undergoing endoscopic screening. Our study also reinforces the importance of risk-reducing lifestyle changes (for example, smoking cessation), which may account for another 34% to 46% of the variation in risk (13) .
In conclusion, our study finds that race is an independent determinant of ACN at screening colonoscopy, but in contrast to several previously published studies, we find that risk is higher among white persons than black persons overall, particularly after adjustment for previous screening colonoscopy and other known epidemiologic risk factors. Our findings provide new evidence suggesting that disparities in access to screening and differential exposure to modifiable risk factors rather than genetic differences are largely responsible for the higher overall incidence of CRC among black persons, especially men. Future studies are warranted to better define the extent to which genetic or biological factors might explain the predilection for proximal disease among black persons.
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